Coming to help you
Christophe Van Huffel
Blockchain applications, genomics, oncology
Christophe has worked in executive positions for several biotech companies including Millennium Pharmaceuticals (now Takeda), Eppendorf, OncoDNA and Targetome. Christophe has also gained invaluable knowledge of the US biotech market. As a scientist, Christophe did basic research in the lab of Nobel Prize winner Bruce Beutler.
Biomanufacturing, monoclonal antibodies, ATMPs
With WBC, Didier has already launched three biotech companies : Amhyspin, Revatis and Synabs. Didier remained CEO of the third one, a rapidly growing contract research and manufacturing organization. He is also one of the co-founders of MasTherCell, a successful contract manufacturing organization specialized in cell therapy products.
Portfolio management, cell therapy, implantable/class III medical devices
Equipped with dual MD and MBA training, Enrico started his career at Aventis spin-out ProSkelia-ProStrakan before founding Bone Therapeutics and leading the company to IPO. As a serial entrepreneur, with Graftys as his latest venture, Enrico knows his way through the complex matters of advanced therapies and medical devices regulations.